Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40009499
Localisation
India
Asia
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
26/09/2024
Statut
Classification
1.5°C
Année cible
FY2033
Statut
Targets set
Classification
1.5°C
Année cible
FY2050
Overall Net-Zero Target: Aragen Life Sciences Limited commits to reach net-zero greenhouse gas emissions across the value chain by FY2050. Near-Term Targets: Aragen Life Sciences Limited commits to reduce absolute scope 1 and 2 GHG emissions 50.4% by FY2033 from a FY2023 base year.* Aragen Life Sciences Limited also commits to reduce absolute scope 3 GHG emissions 50.4% within the same timeframe.* *The target boundary includes land-related emissions and removals from bioenergy feedstocks. Long-Term Targets: Aragen Life Sciences Limited commits to reduce absolute scope 1, 2 and 3 GHG emissions 90% by FY2050 from a FY2023 base year.* *The target boundary includes land-related emissions and removals from bioenergy feedstocks.
Statut
Targets setAnnée cible
FY2050
Statut
BA1.5 memberDate d'engagement
21/04/2022
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
INE483I01013
LEI
335800Q4L1JN55YF6I18
Source : Science Based Targets initiative | Données publiques